Advanced search
Publication Cover
Hematology Volume 26, 2021 - Issue 1
Submit an article Journal homepage
3,482
Views
8
CrossRef citations to date
0
Altmetric
Case Report

Could COVID-19 induce remission of acute leukemia?

Eman Z. Kandeela Clinical Pathology Department, National Cancer Institute, Cairo University, Giza, EgyptView further author information
,
Lobna Refaata Clinical Pathology Department, National Cancer Institute, Cairo University, Giza, EgyptView further author information
,
Raafat Abdel-Fatahb Medical Oncology Department, National Cancer Institute, Cairo University, Giza, EgyptView further author information
,
Mohamed Samrab Medical Oncology Department, National Cancer Institute, Cairo University, Giza, EgyptView further author information
,
Ahmed Bayoumic Pediatric Oncology Department, National Cancer Institute, Cairo University, Giza, EgyptView further author information
,
Mona S. Abdellateifd Cancer Biology Department, National Cancer Institute, Cairo University, Giza, EgyptCorrespondence[email protected]
View further author information
,
Hend Abdel-Hadya Clinical Pathology Department, National Cancer Institute, Cairo University, Giza, EgyptView further author information
,
Mohamed Alib Medical Oncology Department, National Cancer Institute, Cairo University, Giza, EgyptView further author information
&
Medhat Khafagye Surgical Oncology Department, National Cancer Institute, Cairo University, Giza, EgyptView further author information
 show all
Pages 870-873 | Published online: 31 Oct 2021

References

  • Al-Quteimat OM, Mustafa Amer A. The impact of the COVID-19 pandemic on cancer patients. Am J Clin Oncol. 2020;43(6):452–455.
  • Fung M, Babik JM. COVID-19 in immunocompromised hosts: what we know so far. Clin Infect Dis. 2021;72(2):340–350.
  • Paul S, Rausch CR, Jain N, et al. The tissue issue: when to biopsy persistent or refractory disease in classic Hodgkin lymphoma. Acta Haematol. 2021;144(2):130–131.
  • He W, Chen L, Chen L, et al. COVID-19 in persons with haematological cancers. Leukemia. 2020;34(6):1637–1645.
  • Malard F, Genthon A, Brissot E, et al. COVID-19 outcomes in patients with hematologic disease. Bone Marrow Transplant. 2020;55(11):2180–2184.
  • Challenor S, Tucker D. SARS-CoV-2-induced remission of Hodgkin lymphoma. Br J Haematol. 2021;192(415):10–1111.
  • Buckner TW, Dunphy C, Fedoriw YD, et al. Complete spontaneous remission of diffuse large B-cell lymphoma of the maxillary sinus after concurrent infections. Clin Lymphoma Myeloma Leuk. 2012 Dec;12(6):455–458.
  • Burrows SR, Silins SL, Khanna R, et al. Cross-reactive memory T cells for Epstein–Barr virus augment the alloresponse to common human leukocyte antigens: degenerate recognition of major histocompatibility complex-bound peptide by T cells and its role in alloreactivity. Eur J Immunol. 1997;27:1726–1736.
  • D’Orsogna LJ, Amir AL, Zoet YM, et al. New tools to monitor the impact of viral infection on the alloreactive t-cell repertoire. Tissue Antigens. 2009;74:290–297.
  • Starnes CO. Coley’s toxins in perspective. Nature. 1992;357:11–12.
  • Lawler SE, Speranza M-C, Cho C-F, et al. Oncolytic viruses in cancer treatment: a review. JAMA Oncol. 2017;3(6):841–849.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.